Angamuthu Selvapandiyan
New Delhi, DL 110062, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Nucleoside diphosphate kinase (LdNDK2): A metacyclogenesis-regulating kinase essential for Leishmania parasite survival within eukaryotic host cells.
Journal: Microbial pathogenesis
Published: July 02, 2025
The design and synthesis of cysteine protease inhibitors containing isoxazole bearing warheads against Leishmania donovani.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 18, 2025
An Update on Clinical and Pathogenic Spectra of Leishmaniasis.
Journal: Expert reviews in molecular medicine
Published: March 31, 2025
Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines.
Journal: Bioorganic & medicinal chemistry
Published: February 18, 2025
Profiling HIV1-host protein-protein interaction networks in patient-derived exosome proteins: impact on pathophysiology and innate immune pathways.
Journal: Virology journal
Published: December 31, 2024
Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa.
Journal: Diagnostic microbiology and infectious disease
Published: October 12, 2024
Mechanistic insights into LdCen1-LdDRP interaction facilitating UV-induced DNA damage repair in Leishmania donovani.
Journal: Medical microbiology and immunology
Published: September 19, 2024
Design, synthesis and biological activity of peptidyl β-nitrostyrenes as cysteine protease inhibitors against Leishmania donovani.
Journal: RSC advances
Published: September 09, 2024
Identifying Rab2 Protein as a Key Interactor of Centrin1 Essential for Leishmania donovani Growth.
Journal: ACS infectious diseases
Published: August 07, 2024
An update on recombinant vaccines against leishmaniasis.
Journal: The Indian journal of medical research
Published: July 22, 2024
Prevention of nodules and enhancement of antibody response to genetically engineered recombinant vaccine against Human Chorionic Gonadotropin (hCG) for contraception.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: June 21, 2024
Last Updated: 09/26/2026